AGAMREE Approval: What this means for you and your family
by: Parent Project Muscular Dystrophy
PPMD was recently joined by Dr. Aravindhan Veerapandiyan of Arkansas Children’s Hospital to discuss the FDA’s recent approval of AGAMREE (vamorolone), a new steroid approved for the treatment of Duchenne muscular dystrophy in individuals aged 2 years and older.